Search Results

You are looking at 1 - 10 of 577 items for :

  • "Surveillance" x
Clear All
Full access

Melissa Magrath, Edward Yang, Chul Ahn, Christian A. Mayorga, Purva Gopal, Caitlin C. Murphy, Samir Gupta, Deepak Agrawal, Ethan A. Halm, Eric K. Borton, Celette Sugg Skinner and Amit G. Singal

, permitting simultaneous removal of precancerous lesions. 2 , 3 Surveillance colonoscopy is required after polypectomy given an elevated risk of recurrent polyps and cancer. 4 , 5 The long-term effectiveness of colonoscopy-based screening depends on

Full access

David D. Buethe and Julio Pow-Sang

The year 2012 marks the 10th anniversary of the initial reporting of active surveillance (AS) as a management strategy for low-risk prostate cancer. 1 , 2 Since the widespread use of prostate-specific antigen (PSA) beginning in the early 1990s

Full access

Nina D. Wagner-Johnston and Nancy L. Bartlett

imaging studies in cases of lymphoma Analyze the cost-effectiveness of imaging studies in the surveillance of patients with lymphoma Evaluate the risk for cancer associated with radiation exposure from imaging studies L arge randomized trials of

Full access

Randy C. Miles, Christoph I. Lee, Qin Sun, Aasthaa Bansal, Gary H. Lyman, Jennifer M. Specht, Catherine R. Fedorenko, Mikael Anne Greenwood-Hickman, Scott D. Ramsey and Janie M. Lee

low-value practices in oncology that could be avoided without impacting patient care was released through the Choosing Wisely initiative in partnership with ASCO. 3 , 4 Surveillance testing of asymptomatic breast cancer survivors using advanced

Full access

Benjamin R. Roman, Snehal G. Patel, Marilene B. Wang, Anna M. Pou, F. Christopher Holsinger, David Myssiorek, David Goldenberg, Samuel Swisher-McClure, Alexander Lin, Jatin P. Shah and Judy A. Shea

Background Routine surveillance imaging for asymptomatic patients who have completed initial treatment and had 1 negative baseline scan is not recommended in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Head and Neck

Full access

Amit G. Singal, Jorge A. Marrero and Adam Yopp

early-stage HCC achieve 5-year survival rates near 70% with resection and transplantation, whereas those with advanced HCC have a median survival of less than 1 year. 4 , 5 Surveillance using ultrasound at 6-month intervals is recommended in patients

Full access

Crystal Denlinger and Terry S. Langbaum

For most cancers, intensive surveillance after treatment has not been shown to improve survival, and there is growing concern about radiation exposure from routine imaging, according to Crystal Denlinger, MD, Assistant Professor, Fox Chase Cancer

Full access

Mark D. Tyson and Sam S. Chang

half of these recurrences will occur within the first 2 years, 5 a clear rationale exists for optimizing surveillance strategies for patients who have undergone surgical resection for clinically localized RCC. Treating physicians, however, disagree

Full access

Laurence Klotz

. Int J Radiat Oncol Biol Phys 2001 ; 50 : 615 – 620 . 19. Kakehi Y . PSA DT in Japanese active surveillance cohort (48 patients) . Jpn J Clin Oncol 2003 ; 33 : 1 – 5 . 20. Egawa S Arai Y Tobisu K . Use of pretreatment

Full access

Kathryn J. Ruddy, Lindsey Sangaralingham, Rachel A. Freedman, Sarah S. Mougalian, Heather Neuman, Caprice Greenberg, Ahmedin Jemal, Narjust Duma, Tufia C. Haddad, Valerie Lemaine, Karthik Ghosh, Tina J. Hieken, Katie Hunt, Celine Vachon, Cary P. Gross and Nilay D. Shah

Breast cancer survivors who have residual breast tissue are recommended to undergo mammographic surveillance annually. ASCO, the American Cancer Society (ACS), and NCCN recommend annual mammograms beginning at 1 year after the mammogram that led